entertainment -WSS

entertainment

author：entertainment 2025-10-01 01:51:04 - browse：2

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

Alnylam Pharmaceuticals said Thursday that sales of its treatments for rare diseases grew 43% in the second quarter compared to the year-ago period, as the biotech prepares for a key meeting with the Food and Drug Administration in September.

Net product sales in the quarter were $306 million, led by Amvuttra, the company’s RNAi treatment for hereditary ATTR, with sales of $132 million, exceeding Wall Street forecasts. Sales of Onpattro, its older medicine for hereditary ATTR, were $91 million, slightly less than expectations.

The FDA has scheduled a meeting of outside experts on Sept. 13 to discuss the company’s application to expand the indication for Onpattro to include ATTR-CM, a related condition that affects the heart. The FDA decision is due by Oct. 8. An expansion would open a much larger market for the drug than its current approval, which largely targets nerve-related damage.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Why Novartis is changing the name of its research labs

leisure time

WSS

The Sacklers, horror, and ‘The Fall of the House of Usher’

NIH nominee Bertagnolli will get October confirmation hearing

Biotech incubator Curie.Bio graduates its first startup

Illumina names Agilent executive as new CEO

The new shift in health care is toward less care

A clever new way to fix Medicaid and graduate medical education

hotspot

entertainment

hotspot

At least 13 dead in Texas as scorching temps continue

Snackable artificial intelligence, expert AI, and the pharma industry

Alkermes shareholders re

Crinetics acromegaly drug succeeds in late

Tori Bowie and the unacceptable rates of Black maternal death

Diversify hospital leadership teams to protect BIPOC patient health

Peter Hotez and the public health issue of online harassment

Victims of gun violence feel impacts long after bullet wound

Supreme Court strikes down use of affirmative action

HPV cancer vaccine study demonstrates efficacy

Wikipedia

Medicaid rebukes states for mistakenly disenrolling children

ALS advocates say criticism of new drugs misses bigger picture

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

More doctors should go into startup world

Excited delirium, Elijah McClain, and emergency physicians

Extreme heat events are a public health emergency

knowledge

leisure time

entertainment

hotspot